Jim Farmer
About Jim Farmer
Jim Farmer serves as the Vice President of Clinical Operations at RAPT Therapeutics, a position he has held since 2022. He has extensive experience in clinical operations, having previously worked in various leadership roles at companies such as Coherus BioSciences, Portola Pharmaceuticals, and Nektar Therapeutics.
Current Role at RAPT Therapeutics
Jim Farmer serves as the Vice President of Clinical Operations at RAPT Therapeutics, a position he has held since 2022. He is based in South San Francisco, California. In this role, he oversees clinical operations, ensuring the effective management and execution of clinical trials. His leadership contributes to the advancement of RAPT Therapeutics' innovative therapies.
Previous Experience in Clinical Operations
Prior to his current role, Jim Farmer held several significant positions in clinical operations. He worked as Senior Director of Clinical Operations at Coherus BioSciences for 10 months in 2016-2017. He also served as Director of Clinical Operations at Portola Pharmaceuticals from 2014 to 2016, and at Geron from 2011 to 2012. His experience includes a tenure at Nektar Therapeutics from 2008 to 2011, and at Onyx Pharmaceuticals from 2012 to 2014.
Education and Academic Background
Jim Farmer obtained his Bachelor of Science (BSc) degree in Natural Sciences from Indiana University of Pennsylvania, where he studied from 1986 to 1990. His foundational education also includes attendance at JHS 1986 from 1982 to 1986 and Effingham Central Junior High from 1980 to 1982.
Career Progression in the Pharmaceutical Industry
Jim Farmer's career in the pharmaceutical industry includes various leadership roles. He was a Clinical Program Manager at Shire Pharmaceuticals in 2004-2005. He later transitioned to Travere Therapeutics as Senior Director of Strategy & Operations from 2019 to 2022, and held the position of Senior Director of Clinical Operations at NantKwest from 2017 to 2018. His diverse experience spans over two decades in clinical operations.